Free Republic
Browse · Search 		General/Chat
Topics · Post Article

To: nickcarraway; Jane Long; ransomnote
Holy moly, maybe there's something in addition at work, on a CoupFlu vaxx candidate, from 2022...

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial

18 posted on 12/07/2023 1:24:33 PM PST by mewzilla (Never give up; never surrender!)
[ Post Reply | Private Reply | To 1 | View Replies ]

To: mewzilla
And from 2020, I'll just toss this one in...

Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Check out the last paragraph.

20 posted on 12/07/2023 1:27:43 PM PST by mewzilla (Never give up; never surrender!)
[ Post Reply | Private Reply | To 18 | View Replies ]

Free Republic
Browse · Search 		General/Chat
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson